Bug DNA Storage Gadget Gets FDA Classification
Published Date: 5/9/2025
Rule
Summary
The FDA is officially putting microbial nucleic acid storage and stabilization devices into a special safety category called Class II. This means these devices will have clear rules to keep them safe and effective, helping patients get better access to cool new medical tech faster. If you make or use these devices, expect smoother approvals and no surprise costs or delays.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Device moved into Class II rules
The FDA is officially classifying the microbial nucleic acid storage and stabilization device as Class II (special controls). The special controls will be added to the device's codified classification, which changes the regulatory requirements that makers of these devices must meet.
FDA says access and safety improve
The FDA states that classifying this device into Class II will provide a reasonable assurance of safety and effectiveness. The Agency also says this action will enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in